SCHEMBL8871355

SCHEMBL8871355

O=c1nc[nH]c2ccc(N3CCCCC3)cc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IP6K1 Q92551 10/20 0.62
▸ IP6K3 Q96PC2 4/20 0.59
▸ HSD17B10 Q99714 2/20 0.49
▸ AR P10275 1/20 0.46
▸ KIF11 P52732 2/20 0.44
▸ IP6K2 Q9UHH9 1/20 0.44
▸ MAP4K4 O95819 1/20 0.43
▸ PIK3CD O00329 1/20 0.43
▸ PIK3CA P42336 1/20 0.43
▸ PIK3CB P42338 1/20 0.43
▸ ERCC1 P07992 1/20 0.43
▸ DNASE1 P24855 1/20 0.43
▸ FEN1 P39748 1/20 0.43
▸ ERCC4 Q92889 1/20 0.43
▸ PDE3B Q13370 1/20 0.42
▸ PDE3A Q14432 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ ALOX15 P16050 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8976318 0.98 IP6K1 (0.61) IP6K1IP6K3HSD17B10ARKIF11
SCHEMBL8871223 0.86 PIK3CD (0.60) IP6K1IP6K3HSD17B10KIF11PIK3CD
SCHEMBL23122450 0.78 IP6K1 (0.60) IP6K1IP6K3MAP4K4PIK3CDPIK3CA
SCHEMBL8871369 0.77 IP6K1 (1.00) IP6K1IP6K3HSD17B10IP6K2MAP4K4
SCHEMBL1444275 0.76 IP6K1 (0.59) IP6K1IP6K3MAP4K4PIK3CDPIK3CA
SCHEMBL14481463 0.75 PIK3CD (0.65) IP6K1IP6K3HSD17B10KIF11PIK3CD
SCHEMBL27517100 0.75 IP6K1 (0.64) IP6K1IP6K3MAP4K4PIK3CDPIK3CA
SCHEMBL8976326 0.75 IP6K1 (1.00) IP6K1IP6K3HSD17B10IP6K2PIK3CD
SCHEMBL14877166 0.71 KIF11 (0.47) IP6K1ARKIF11
SCHEMBL1584889 0.71 PIM1 (0.56) MAP4K4MEN1ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5616582-A Use as anticancer agents; e.g. gefitinib ZENECA LIMITED (GB) 1997-04-01 — — US disclosed
US-5580870-A ANTICARCINOGENIC AGENTS ZENECA LIMITED (GB) 1996-12-03 — — US disclosed
EP-0602851-B1 Quinazoline derivatives ZENECA LTD (GB) 1996-10-09 — — EP disclosed
EP-0566226-B1 Quinazoline derivatives ZENECA LTD (GB) 1995-11-08 — — EP disclosed
US-5457105-A anticancer use; e.g. 4-(3'-chloro-4'-fluoroanilino)-6,7-dimethoxyquinazoline (gefitinib) ZENECA LIMITED (GB) 1995-10-10 — — US disclosed
EP-0602851-A1 Quinazoline derivatives ZENECA LIMITED (GB) 1994-06-22 — — EP disclosed
EP-0566226-A1 Quinazoline derivatives ZENECA LIMITED (GB) 1993-10-20 — — EP disclosed
Send feedback